The stock of OKYO Pharma Limited (OKYO) has seen a 10.88% increase in the past week, with a 22.60% gain in the past month, and a 23.89% flourish in the past quarter. The volatility ratio for the week is 5.60%, and the volatility levels for the past 30 days are at 5.76% for OKYO. The simple moving average for the last 20 days is 15.39% for OKYO stock, with a simple moving average of 5.18% for the last 200 days.
Is It Worth Investing in OKYO Pharma Limited (NASDAQ: OKYO) Right Now?
The 36-month beta value for OKYO is at -0.25. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OKYO is 24.54M, and currently, shorts hold a 0.88% of that float. The average trading volume for OKYO on January 08, 2025 was 59.72K shares.
OKYO) stock’s latest price update
OKYO Pharma Limited (NASDAQ: OKYO)’s stock price has increased by 9.03 compared to its previous closing price of 1.17. However, the company has seen a 10.88% increase in its stock price over the last five trading sessions. accesswire.com reported 2024-11-15 that ORLANDO, FL / ACCESSWIRE / November 15, 2024 / RedChip Companies will air interviews with MUSQ Global Music Industry ETF (NYSE:MUSQ) and OKYO Pharma Ltd. (Nasdaq:OKYO) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, November 16, at 7 p.m.
OKYO Trading at 16.88% from the 50-Day Moving Average
After a stumble in the market that brought OKYO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -34.62% of loss for the given period.
Volatility was left at 5.76%, however, over the last 30 days, the volatility rate increased by 5.60%, as shares surge +14.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.17% lower at present.
During the last 5 trading sessions, OKYO rose by +6.10%, which changed the moving average for the period of 200-days by -20.52% in comparison to the 20-day moving average, which settled at $1.1022. In addition, OKYO Pharma Limited saw 10.88% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for OKYO
The total capital return value is set at 0.0.
Currently, EBITDA for the company is 15745.87 with net debt to EBITDA at 52.51.
Conclusion
In conclusion, OKYO Pharma Limited (OKYO) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
